gastric bypass and semaglutide Bariatric Surgery Outperforms GLP-1s in Weight Loss Bariatric Surgery vs. Weight-Loss Drugs:

Emerging research suggests these mechanisms may lower chronic inflammation markers linked to weight-related metabolic disease

As GLP1 use rises, new patient volume for hypertension and cholesterol therapies has declined, while GERD treatments remain stable due to GLP1s mixed impact, showing ripple effects across multiple disease areas

Meal timing around your semaglutide shot matters more than you might think

And other biotech news brought to you by The Readout newsletter

Device and Health Care Groups have developed an initial checklist for providers to consider during the FDA’s enforcement discretion period.